Treprostinil and Clinical Outcome in Pulmonary Hypertension and Interstitial Lung Disease Is All Clear?

被引：0
|
作者：
Carbone, Roberto G. [1 ]
Monselise, Assaf [2 ]
Puppo, Francesco [1 ]
机构：
[1] Univ Genoa, Dept Internal Med, Genoa, Italy
[2] Clalit Hlth Serv, Tel Aviv, Israel
来源：
CHEST | 2023年 / 164卷 / 01期
关键词：
FIBROSIS;
D O I：
10.1016/j.chest.2023.04.015
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：e21 / e21
页数：1
相关论文
共 50 条
  • [1] Inhaled Treprostinil in Pulmonary Hypertension Due to Interstitial Lung Disease
    Waxman, Aaron
    Restrepo-Jaramillo, Ricardo
    Thenappan, Thenappan
    Ravichandran, Ashwin
    Engel, Peter
    Bajwa, Abubakr
    Allen, Roblee
    Feldman, Jeremy
    Argula, Rahul
    Smith, Peter
    Rollins, Kristan
    Deng, Chunqin
    Peterson, Leigh
    Bell, Heidi
    Tapson, Victor
    Nathan, Steven D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (04): : 325 - 334
  • [2] The Effect of Subcutaneous Treprostinil on Pulmonary Hypertension Associated with Interstitial Lung Disease
    Sadushi-Kolici, Roela
    Shafran, Inbal
    Prosch, Helmut
    Skoro-Sajer, Nika
    Gerges, Christin
    Lang, Irene
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [3] Vasoreactivity and inhaled treprostinil response in interstitial lung disease pulmonary hypertension
    Harder, Eileen M.
    Rahaghi, Farbod N.
    Leopold, Jane A.
    Systrom, David M.
    Washko, George R.
    Waxman, Aaron B.
    ERJ OPEN RESEARCH, 2024, 10 (06)
  • [4] Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
    Behr, Juergen
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205 (02) : 144 - 146
  • [5] Inhaled Treprostinil Dosage in Pulmonary Hypertension Associated With Interstitial Lung Disease and Its Effects on Clinical Outcomes
    Nathan, Steven D.
    Deng, Chunqin
    King, Christopher S.
    DuBrock, Hilary M.
    Elwing, Jean
    Rajagopal, Sudarshan
    Rischard, Franz
    Sahay, Sandeep
    Broderick, Meredith
    Shen, Eric
    Smith, Peter
    Tapson, Victor F.
    Waxman, Aaron B.
    CHEST, 2023, 163 (02) : 398 - 406
  • [6] Efficacy and determinants of response to inhaled treprostinil in pulmonary hypertension - interstitial lung disease
    Balakrishnan, Bathmapriya
    Azar, Jehad
    Farha, Samar
    Goyanes, Alice M.
    Lane, James E.
    Paul, Deborah
    Highland, Kristin B.
    Wang, Yifan
    Wang, Xiaofeng
    Tonelli, Adriano R.
    RESPIRATORY MEDICINE, 2024, 234
  • [7] COMPARISON OF EFFECTS OF INHALED TREPROSTINIL ON LUNG FUNCTION IN PATIENTS WITH PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND PULMONARY ARTERIAL HYPERTENSION
    Nathan, Steven
    Tapson, Victor
    Ramani, Gautam
    Medarov, Boris
    Levine, Deborah
    Burger, Charles
    El-Kersh, Karim
    Shen, Eric
    Rao, Youlan
    Smith, Peter
    Waxman, Aaron
    CHEST, 2021, 160 (04) : 2244A - 2246A
  • [8] Interstitial lung disease with pulmonary hypertension and the potential for inhaled Treprostinil: A single centre perspective
    Ramjug, S.
    Hayton, C.
    Rivera-Ortega, P.
    Leonard, C.
    Morris, H.
    Zakis, K.
    Swale, J.
    Garfoot, T.
    Newman, K.
    Avram, C.
    Blaikley, J.
    Chaudhuri, N.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [9] Clinical assessment for pulmonary hypertension in interstitial lung disease
    Chan, Roseanne K.
    Horrigan, Mark
    Goh, Nicole S. L.
    Khor, Yet H.
    INTERNAL MEDICINE JOURNAL, 2023, 53 (08) : 1415 - 1422
  • [10] DOSE RESPONSE ANALYSIS OF INHALED TREPROSTINIL IN PULMONARY HYPERTENSION ASSOCIATED WITH INTERSTITIAL LUNG DISEASE AND ITS EFFECTS ON CLINICAL WORSENING
    Waxman, Aaron
    Nathan, Steven
    Fisher, Micah
    Ford, H. James
    Gagermeier, James
    Parambil, Joseph
    Raina, Amresh
    Zwicke, Dianne
    Gerke, Alicia
    Shen, Eric
    Lee, Dasom
    Rao, Youlan
    Tapson, Victor
    CHEST, 2021, 160 (04) : 2279A - 2280A
12345